Home/Pipeline/Sanofi Established Products Portfolio

Sanofi Established Products Portfolio

Various CNS Disorders

Commercial AcquisitionActive

Key Facts

Indication
Various CNS Disorders
Phase
Commercial Acquisition
Status
Active
Company

About Neuraxpharm

Neuraxpharm is a well-established, privately-held European pharmaceutical company specializing in CNS disorders, operating in a high-need therapeutic area affecting one in three people globally. The company has evolved from a generic drug focus to a diversified CNS specialist with a portfolio spanning generics, branded established products, digital health devices, and partnerships for innovative therapies. Its strategy is built on geographic expansion across Europe, strategic acquisitions, and forging alliances to enhance its product offerings and address gaps in CNS care, positioning it for continued growth in a complex but critical market.

View full company profile

Other Various CNS Disorders Drugs

DrugCompanyPhase
Platform for NeuropeptidesMetP PharmaResearch